Joel Ackerman, Chief Executive Officer at CHAMPIONS ONCOLOGY, INC. (CSBR), bought 3,201 shares at $1.70 ($5K) on 2016-10-18, disclosed to the SEC on 2016-10-20.
Open-market purchase of $5k CSBR by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.69 | 201 | $340 | 6.3% |
| 2 | $1.69 | 381 | $644 | 11.9% |
| 3 | $1.69 | 201 | $340 | 6.3% |
| 4 | $1.70 | 1,000 | $2K | 31.3% |
| 5 | $1.70 | 418 | $711 | 13.1% |
| 6 | $1.70 | 1,000 |
| $2K |
| 31.3% |
| Total | $1.70 avg | 3,201 | $5K | 100% |
| Filing → |
| DVA | SELL | 2021-08-06 | $9.9M | — | Filing → |
| CSBR | SELL | 2018-10-03 | $767K | — | Filing → |
| CSBR | BUY | 2016-10-14 | $14K | — | Filing → |